Clincosm LogoSign in Get a demo

The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice

Sponsor
ClinAmygate (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04558203
Collaborator
(none)
3,112
Enrollment
1
Location
20.6
Anticipated Duration (Months)
151.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study explore the relationship between COVID-19 and the induction of autoimmune diseases.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    It has been suggested that the shared pathogenetic mechanisms and clinical-radiological aspects between the hyper-inflammatory diseases and Covid-19 may suggest that SARS-CoV-2 could act as a triggering factor for the development of a rapid autoimmune and/or autoinflammatory dysregulation, leading to the severe interstitial pneumonia, in genetic predisposed individuals.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    3112 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice
    Actual Study Start Date :
    Sep 22, 2020
    Actual Primary Completion Date :
    May 10, 2022
    Anticipated Study Completion Date :
    Jun 10, 2022

    Outcome Measures

    Primary Outcome Measures

    1. incidence of autoimmune conditions [Two-weeks]

      incidence of autoimmune conditions

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • COVID-19 cases
    Exclusion Criteria:
    • not proved to be COVID-19 cases

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Asalam Maadi Cairo Egypt 11433

    Sponsors and Collaborators

    • ClinAmygate

    Investigators

    • Principal Investigator: Emad R Issak, MD, Asalam Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    ClinAmygate
    ClinicalTrials.gov Identifier:
    NCT04558203
    Other Study ID Numbers:
    • PR0014
    First Posted:
    Sep 22, 2020
    Last Update Posted:
    May 31, 2022
    Last Verified:
    May 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    COVID-19
    Autoimmune Diseases

    Study Results

    No Results Posted as of May 31, 2022